DeepMind Expedite Discovery of Drugs
- Read more about DeepMind Expedite Discovery of Drugs
- Log in or register to post comments
DeepMind, a subsidiary of Alphabet Inc., has announced that it can predict the structure of proteins that could expedite the discovery of drugs.
Scientists spend a great deal of effort to create a three-dimensional shape of proteins, which then explains their behavior. The process could take years; however, using AI, DeepMind claims to do so in days.
DeepMind, a UK-based startup, was acquired by Alphabet Inc., the parent company of Google Inc., in 2014 for about $600 Million.